BioAstin® OKd in EU

KAILUA-KONA , Hawaii—Cyanotech Corp. (www.cyanotech.com) received official regulatory approval (substantial equivalence) for its BioAstin® Natural Astaxanthin as a novel food in the European Union. This allows importation of BioAstin into all 27 EU member countries, providing Cyanotech access to a market of more than 487 million people.

“Europe is the ideal market for BioAstin,” said Gerald Cysewski, Ph.D., chief executive officer (CEO) and founder of Cyanotech. “Europe’s demographics in terms of age, income and education levels match perfectly with BioAstin’s uses and benefits. We felt it was important to officially register BioAstin’s active ingredient ‘astaxanthin’ for our customers’ benefit.”